Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS

Summary

ULSC-CV-01 is a clinical trial that comprises both Phase 1 and Phase 2a, which will be conducted sequentially. This trial will evaluate the safety and potential efficacy of allogeneic Umbilical Cord Lining Stem Cells (ULSC), which are a type of umbilical cord tissue derived mesenchymal stem cells (MSC), with intravenous (IV) administration in hospitalized patients with acute respiratory distress syndrome (ARDS) due to COVID-19.

Timeline

Start

2020-12-23

Primary completion

2023-05-12

Completion

2023-05-12

Drugs

Indications